Buda Juice (BUDA) has secured distribution for its Cherry Limeade product at Walmart, expanding its presence to 246 stores across nine states and testing its cold-chain logistics on a larger scale. However, despite this expansion, the revenue growth impact is expected to be modest, adding about $1 million annually or roughly 11% of projected fiscal year 2025 revenue. The company faces operational challenges such as gross margin compression to 39.5% and limited free cash flow, driven by freight and supply chain pressures as it expands beyond Texas. Given these factors and its valuation at about six times sales with mid-teens growth, Buda Juice is considered overvalued, leading to a maintained 'Sell' rating due to volatile margins and uncertain national brand growth.
Phemex has expanded its traditional finance (TradFi) offerings by introducing SPCXUSDT Pre-Market Perpetual Futures, allowing users to trade secondary-market prices linked to SpaceX in a 24/7 USDT-settled environment. This move aims to provide broade...
BizClik Media announced a Water Positivity Forum during Sustainability LIVE at London Climate Action Week on June 25, 2026. The invite-only event, sponsored by Philip Morris International, will gather over 250 senior sustainability executives to disc...
American Airlines shares edged up after initially falling in premarket trading, following the company's Q2 revenue forecast in line with estimates and an adjusted EPS outlook ranging from a small loss to a small profit. However, the airline lowered i...
Mexican courts ruled that Capstone Copper Corp. must pay over $50 million in unpaid royalties to Minera Portree de Zacatecas (MPZ) for its 2% Net Smelter Return royalty on five mining concessions at the Cozamin copper-silver mine, dating back to 2019...
Conexeu Sciences Inc. began trading on Nasdaq on May 21, 2026, introducing a regenerative tissue platform called CXU™ that aims to address wound care, breast reconstruction, and aesthetic medicine. Their 3D-bioprinted B.R.E.A.S.T.™ matrix supports na...
